Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
22.62
Price to sales ratio
2.19
Dividends per share
0.82
Dividend yield %
4.8

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
117
UL
Unilever PLC American Depositary Shares
61.51 USD-0.36%+0.03%+4.38%-14.78%134.15 B USD
220
CL
Colgate-Palmolive Company Common Stock
92.99 USD+0.79%-0.49%+4.85%+3.97%74.41 B USD
399
KMB
Kimberly-Clark Corporation - Common Stock
109.74 USD-2.38%-3.30%+7.50%+2.08%36.43 B USD
453
EL
Estee Lauder Companies, Inc. Common Stock
81.53 USD-1.36%-4.12%-7.18%-10.15%29.50 B USD

Frequently asked questions about Kenvue Inc. Common Stock

What is the Kenvue Inc. Common Stock stock price today?

The current price of Kenvue Inc. Common Stock (KVUE) is 19.19. Over the past 24 hours, the stock has changed by -1.49%. Follow the KVUE chart for real-time price dynamics.

What is the stock ticker of Kenvue Inc. Common Stock?

Kenvue Inc. Common Stock trades under the ticker KVUE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Kenvue Inc. Common Stock stock going up?

KVUE has changed by -2.14% over the last week, +5.56% over the last month, and +27.25% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Kenvue Inc. Common Stock release financial reports?

Yes. You can track Kenvue Inc. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was Kenvue Inc. Common Stock net income for the last quarter?

Kenvue Inc. Common Stock reported net income of 330 M for the last quarter. The previous quarter showed 398 M, which means net income changed by -17.09%.

How many employees does Kenvue Inc. Common Stock have?

As of the latest available data, Kenvue Inc. Common Stock has 22 K employees. Workforce size can provide additional context about the company's scale and operations.

What is Kenvue Inc. Common Stock EBITDA?

Kenvue Inc. Common Stock EBITDA is -6 M, and its EBITDA margin is -0.16%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Kenvue Inc. Common Stock stock?

You can buy Kenvue Inc. Common Stock (KVUE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Kenvue Inc. Common Stock stock?

Investing in Kenvue Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KVUE chart and related analysis on metatrader.com as part of your research.

Kenvue Inc. Common Stock

Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey. Johnson & Johnson announced in November 2021 that it would spin off its consumer health division as a separate company. The new company was named Kenvue in September 2022, and its initial public offering took place in May 2023, raising $3.8 billion in the largest U.S. IPO since 2021, with an initial valuation of about $41 billion. Johnson & Johnson initially retained more than 90% ownership before completing a full separation through a share exchange in July 2023. Kenvue was subsequently added to the S&P 500 Dividend Aristocrats index. CEO Thibaut Mongon initially led Kenvue, which employed about 22,200 people in 2022. Following Mongon’s termination in 2025, Kirk Perry was named interim CEO.

News